Synedica Tirzepatide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Mounjaro,” tirzepatide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of the GLP-1 and GIP receptors, which are natural hormones that makes humans feel full from eating much smaller portions of food.

The Synedica Tirzepatide® 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet.

Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg.

Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.

Always consult your doctor, nurse or pharmacist before using any new medication.

Synedica Tirzepatide® 40mg Injection Pen Kit is available at selected pharmacies across Germany, and potentially free for German citizens who qualify under Gesetzliche Krankenversicherung.

⚠️ Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

🔬 Suitable R&D Applications

🧪 Stability Testing

• Thermal, enzymatic, and oxidative degradation studies

• Shelf-life evaluation & formulation robustness

⚗️ Formulation Development

• Enhances solubility, bioavailability, and structural integrity

• Tailored for injectable, topical, and research-grade use

🧩 Excipient Compatibility Testing

• Evaluates interactions between peptides & inactive components

• Ensures safety, stability, and performance

🔒 Protease Resistance Evaluation

• Assesses susceptibility to enzymatic breakdown

• Supports development of more durable peptide products

📦 Encapsulation & Carrier Systems

• Liposomes, microspheres, and other delivery vehicles

• Protects peptides & enables controlled release

💉 Administration Route Assessment

Optimized for:

• Parenteral delivery (injectables)

• Dermal absorption (cosmetic/topical)

• In vitro research applications

Synedica Semaglutide® Injection Pen Kit is the world’s most advanced weight loss solution. Commonly known as “Ozempic,” semaglutide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of GLP-1, a natural hormone that makes humans feel full from eating much smaller portions of food.

The Synedica Semaglutide® 1mg Injection Pen Kit contains 2 pens, 12 disposable needles and an instruction booklet.

Each pen has 4mg which can be delivered across 4 full doses of 1mg, or in increments of 0.25mg, 0.5mg, 0.75mg or 1mg.

Recommended dosage is 0.25mg for the first 4 weeks, then 0.5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 0.75mg or 1mg.

⚠️ Important Notice

All products are produced exclusively for controlled laboratory research and development applications.
Not for human or animal consumption.

🔬 Suitable R&D Applications

🧪 Stability Testing

• Thermal, enzymatic, and oxidative degradation studies

• Shelf-life evaluation & formulation robustness

⚗️ Formulation Development

• Enhances solubility, bioavailability, and structural integrity

• Tailored for injectable, topical, and research-grade use

🧩 Excipient Compatibility Testing

• Evaluates interactions between peptides & inactive components

• Ensures safety, stability, and performance

🔒 Protease Resistance Evaluation

• Assesses susceptibility to enzymatic breakdown

• Supports development of more durable peptide products

📦 Encapsulation & Carrier Systems

• Liposomes, microspheres, and other delivery vehicles

• Protects peptides & enables controlled release

💉 Administration Route Assessment

Optimized for:

• Parenteral delivery (injectables)

• Dermal absorption (cosmetic/topical)

• In vitro research applications